2021 annual financial data
Monopar Therapeutics 2021 Operating cash flow
Direct answer
Operating cash flow was -7,317,401 USD.
Operating income was -9,127,248 USD and net income was -9,079,200 USD.
Operating cash flow was -7,317,401 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,127,248 USD
- Net income
- -9,079,200 USD
- Operating cash flow
- -7,317,401 USD